pH and H 2 O 2 dual-sensitive nanoparticles enable enhanced and safe glucose-responsive oral insulin delivery for diabetes mellitus treatment
Theranostics · 2024
DOI: 10.7150/thno.98177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Muzi Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technolog…. Hauptthemen laut MEDLINE: Insulin, Nanoparticles, Hydrogen Peroxide, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China.
- College of Pharmacy, Heze University, Heze 274015, China.
- School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, China.
Zitieren
APA
Li, M., Wang, N., Liu, R., Zhang, X., He, W., Zhang, W., Li, J., Peng, C., & Li, Y. (2024). pH and H 2 O 2 dual-sensitive nanoparticles enable enhanced and safe glucose-responsive oral insulin delivery for diabetes mellitus treatment. Theranostics. https://doi.org/10.7150/thno.98177
Vancouver
Li M, Wang N, Liu R, Zhang X, He W, Zhang W, et al. pH and H 2 O 2 dual-sensitive nanoparticles enable enhanced and safe glucose-responsive oral insulin delivery for diabetes mellitus treatment. Theranostics. 2024. doi:10.7150/thno.98177
BibTeX
@article{Li2024,
author = {Li, Muzi and Wang, Nan and Liu, Ruiyuan and Zhang, Xinyue and He, Wei and Zhang, Wen and Li, Jiaxin and Peng, Chen and Li, Yan},
title = {pH and H 2 O 2 dual-sensitive nanoparticles enable enhanced and safe glucose-responsive oral insulin delivery for diabetes mellitus treatment},
journal = {Theranostics},
year = {2024},
doi = {10.7150/thno.98177}
}
EUVIMED